Bellevue Life Valuation
| BLAC Stock | 11.30 0.04 0.36% |
At this time, the firm appears to be overvalued. Bellevue Life Sciences shows a prevailing Real Value of USD9.61 per share. The current price of the firm is USD11.3. Our model approximates the value of Bellevue Life Sciences from analyzing the firm fundamentals such as Shares Outstanding of 4.04 M, return on asset of -0.0298, and Shares Owned By Institutions of 42.94 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bellevue Life's valuation include:
Price Book 3.0618 | Enterprise Value 47.4 M | Enterprise Value Ebitda (98.70) |
Overvalued
Today
Please note that Bellevue Life's price fluctuation is not too volatile at this time. Calculation of the real value of Bellevue Life Sciences is based on 3 months time horizon. Increasing Bellevue Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bellevue Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bellevue Stock. However, Bellevue Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.3 | Real 9.61 | Hype 11.3 |
The real value of Bellevue Stock, also known as its intrinsic value, is the underlying worth of Bellevue Life Sciences Company, which is reflected in its stock price. It is based on Bellevue Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bellevue Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bellevue Life Sciences helps investors to forecast how Bellevue stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bellevue Life more accurately as focusing exclusively on Bellevue Life's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bellevue Life's intrinsic value based on its ongoing forecasts of Bellevue Life's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bellevue Life's closest peers. If more than one evaluation category is relevant for Bellevue Life we suggest using both methods to arrive at a better estimate.
Bellevue Life Cash |
|
Bellevue Valuation Trend
Comparing Bellevue Life's enterprise value against its market capitalization is a good way to estimate the value of Bellevue Life Sciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Bellevue Valuation Data Drivers
Bellevue Life Total Value Analysis
Bellevue Life Sciences is currently forecasted to have valuation of 47.43 M with market capitalization of 45.67 M, debt of 4.11 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Bellevue Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
47.43 M | 45.67 M | 4.11 M |
Bellevue Life Asset Utilization
One of the ways to look at asset utilization of Bellevue is to check how much profit was generated for every dollar of assets it reports. Bellevue Life Sciences shows a negative utilization of assets of -0.0298 percent, losing USD2.98E-4 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Bellevue Life Sciences shows how discouraging it operates for each dollar spent on its assets.Bellevue Life Ownership Allocation
The market capitalization of Bellevue Life Sciences is USD45.67 Million. Bellevue Life Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Bellevue Life Profitability Analysis
Net Income was 403.78 K with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bellevue Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bellevue Life and how it compares across the competition.
About Bellevue Life Valuation
The stock valuation mechanism determines Bellevue Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bellevue Life. We calculate exposure to Bellevue Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bellevue Life's related companies.Bellevue Life Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 5.6 M |
Bellevue Life Current Valuation Indicators
Valuation refers to the process of determining the present value of Bellevue Life Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Bellevue we look at many different elements of the entity such as Bellevue's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Bellevue Life, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Bellevue Life's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Bellevue Life's worth.Complementary Tools for Bellevue Stock analysis
When running Bellevue Life's price analysis, check to measure Bellevue Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellevue Life is operating at the current time. Most of Bellevue Life's value examination focuses on studying past and present price action to predict the probability of Bellevue Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bellevue Life's price. Additionally, you may evaluate how the addition of Bellevue Life to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |